BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17565198)

  • 41. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
    Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
    Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of worse outcome by systemic atherosclerosis following acute ischemic stroke.
    Huang KL; Lee TH; Ryu SJ; Chang YJ
    Acta Neurol Taiwan; 2008 Jun; 17(2):88-93. PubMed ID: 18686647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
    Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
    Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
    Smout J; Cleanthis M; Stansby G
    Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter by Bhindi and Ormerod regarding article, "Aortic arch plaques and risk of recurrent stroke and death".
    Bhindi R; Ormerod OJ
    Circulation; 2010 Jan; 121(2):e10; author reply e12. PubMed ID: 20083715
    [No Abstract]   [Full Text] [Related]  

  • 49. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Giant cell arteritis as a cause of first-ever stroke.
    Wiszniewska M; Devuyst G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):226-30. PubMed ID: 17630482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paracentral strip infarcts of the middle cerebral artery: borderzone ischaemia or cortical artery occlusion?
    Iwanaga T; Arakawa S; Siritho S; Fitt G; Dewey HM; Chambers BR; Donnan GA
    Cerebrovasc Dis; 2009; 27(3):215-22. PubMed ID: 19176953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes.
    Segev A; Strauss BH; Tan M; Buller CE; Mendelsohn AA; Langer A; Goodman SG;
    Int J Cardiol; 2008 Sep; 129(2):233-7. PubMed ID: 17976842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
    Talelli P; Greenwood RJ
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal bleeding after acute ischemic stroke.
    Misra UK; Kalita J; O'Donnell MJ; Kapral M; Silver F
    Neurology; 2009 Jul; 73(2):160-1. PubMed ID: 19597141
    [No Abstract]   [Full Text] [Related]  

  • 58. [Secondary prevention of ischemic cerebral accidents].
    Ducrocq X
    Soins; 2001 Oct; (659):48-50. PubMed ID: 12012687
    [No Abstract]   [Full Text] [Related]  

  • 59. Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.
    Park JH; Kwon HM
    Clin Neurol Neurosurg; 2008 Mar; 110(3):215-21. PubMed ID: 18055103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.